DSIP Overview, Dosing & Safety | Peptide Database

DSIP (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide | Sleep & Stress Modulator

Community Research

Join others researching DSIP — share findings, ask questions, and learn from real experiences

DSIP is a naturally occurring nonapeptide discovered in 1974 in rabbit brain. Originally isolated for sleep-promoting properties, it has diverse neuromodulatory effects including stress reduction, pain modulation, and endocrine regulation without traditional sedative effects.

Modulates multiple neurotransmitter systems including GABA enhancement, NMDA receptor interaction, and endogenous opioid system modulation. Also regulates hypothalamic-pituitary-adrenal axis for stress response.

Molecular Data

Tryptophan

Position 1

Alanine

Position 2

Glycine

Position 3

Position 4

Aspartic Acid

Position 5

Position 6

Serine

Position 7

Position 8

Glutamic Acid

Position 9

Research Indications

Promotes delta wave sleep, the most restorative sleep phase for physical recovery.

Reduces sleep latency and nocturnal awakenings without morning grogginess.

Supports natural sleep cycles rather than forcing sedation like traditional sleep aids.

Helps regulate cortisol and stress response through HPA axis modulation.

Supports emotional balance without sedation.

May help reduce anxiety through neuromodulatory effects.

Significantly reduced pain levels in 6 of 7 patients with chronic pain conditions.

Helps manage withdrawal symptoms in alcohol and opioid-dependent patients.

Supports post-training recovery through enhanced sleep quality.

Dosing Protocols

Subcutaneous injection is the standard route. Best taken 30-60 minutes before bedtime. Some prefer earlier evening dosing for gradual onset.

Sleep enhancement

100-200mcg

Once nightly

SubQ

Chronic pain support

250-300mcg

Daily

SubQ or IV

Stress management

150mcg

Evening

Withdrawal support

200-300mcg

Twice daily

IV preferred

Athletic recovery

100-150mcg

Post-training

Reconstitution Instructions

DSIP peptide vial (1-5mg typical)

Bacteriostatic water (1-2mL)

Insulin syringes (0.3-0.5mL)

Alcohol swabs

Sterile needle for mixing

1 Clean vial tops with alcohol swab and let dry completely

2 For 1mg vial, add 1mL bacteriostatic water (creates 1000mcg/mL)

3 Inject water slowly down vial side to prevent foaming

4 Gently roll between palms - do not shake

5 Solution should be clear and colorless

6 For 100mcg dose, draw 0.1mL (10 units on insulin syringe)

7 Store reconstituted peptide in refrigerator immediately

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Generally well-tolerated with minimal side effects

Mild drowsiness or dizziness initially (some users)

Occasional headaches in sensitive individuals

No tolerance or dependence reported in studies

Stop Signs - Discontinue if:

Excessive daytime sedation

Paradoxical insomnia or agitation

Persistent headaches

Any allergic reactions

Mood changes or depression

Unusual dreams causing distress

Contraindications

Avoid driving until effects are known

Pregnancy or breastfeeding

Quality Checklist

Good Signs

White lyophilized powder before reconstitution

Clear and colorless solution when properly mixed

Reputable source with third-party testing

Warning Signs

Short stability period - use within 14 days when reconstituted

Protect from light exposure and temperature fluctuations

Limited nasal formulation stability (use within 10 days)

Bad Signs

Yellow or cloudy solution indicates degradation or contamination

Discolored powder

Frequently Asked Questions

How quickly does DSIP improve sleep compared to melatonin?

DSIP acts within 30-60 minutes of injection with noticeable sleep pressure by the first dose. It works faster than melatonin (which takes 1-2 hours) and promotes natural delta-wave sleep architecture rather than sedation. Most users report deeper, more restorative sleep from night one of use.

Will DSIP cause dependence or tolerance like sleeping pills?

No dependence or tolerance has been reported with DSIP in clinical studies, unlike traditional sedatives. Its naturally occurring structure and neuromodulatory mechanism (GABA enhancement, HPA axis modulation) work through physiological pathways rather than receptor desensitization, making it suitable for short cycles without habituation concerns.

Can DSIP help with chronic pain like the research suggests?

One clinical study found 6 of 7 chronic pain patients experienced significant pain reduction with IV DSIP (25 nmol for 10 days). It works through multiple pathways including endogenous opioid modulation and stress reduction. However, human data is limited primarily to small studies, so pain management requires medical oversight.

Is DSIP useful for managing withdrawal from alcohol or opioids?

Yes, research shows DSIP is remarkably effective for withdrawal management—87% of alcoholics and 97% of opioid addicts showed beneficial effects in clinical trials using IV administration (25 nmol/kg). It reduces withdrawal symptoms through immediate onset and HPA axis normalization, making it relevant for addiction medicine.

References

Double-blind placebo-controlled study; DSIP (15-30 nmol for 6 consecutive nights) showed higher sleep efficiency and shorter sleep latency, though statistical effects were weak.

7 patients with chronic pain (migraine, vasomotor headaches); 25 nmol IV DSIP for 10 days significantly reduced pain levels in 6 of 7 patients.

107 patients (47 alcohol, 60 opiate withdrawal); DSIP (25 nmol/kg IV) produced beneficial effects in 97% of opiate addicts and 87% of alcoholics with immediate onset and lasting symptom relief.

6 normal volunteers; 25 nmol/kg IV DSIP induced 59% increase in total sleep time within 130 minutes; improved subsequent night sleep efficiency without sedation.

120 mcg/kg intranasal DSIP for 8 days accelerated motor function recovery (rotarod test) after focal stroke in rats; brain infarction was smaller but not statistically significant.

DSIP (25 nmol/kg IV) administered to 67 patients; beneficial effect in 48 of 49 evaluable patients (22 alcoholics and 26 of 27 opiate addicts) with good tolerance.

Related Peptides

Complementary anxiolytic effects.

Different mechanisms; can optimize 24-hour function.

Both support circadian regulation and sleep quality.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.